Semisynthetic neoclerodanes as kappa opioid receptor probes

被引:23
|
作者
Lovell, Kimberly M. [1 ]
Vasiljevik, Tamara [1 ]
Araya, Juan J. [1 ]
Lozama, Anthony [2 ]
Prevatt-Smith, Katherine M. [1 ]
Day, Victor W. [1 ]
Dersch, Christina M. [3 ]
Rothman, Richard B. [3 ]
Butelman, Eduardo R. [4 ]
Kreek, Mary Jeanne [4 ]
Prisinzano, Thomas E. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[3] NIDA, Clin Psychopharmacol Sect, IRP, DHHS, Baltimore, MD 21224 USA
[4] Rockefeller Univ, Lab Biol Addict Dis, New York, NY USA
基金
美国国家科学基金会;
关键词
Natural product; Salvinorin A; Salvia divinorum; Kappa opioid receptor; Hallucinogen; Furan; SALVINORIN-A; SALVIA-DIVINORUM; NATURAL-PRODUCTS; LIGANDS; AGONIST; TRANSFORMATIONS; IDENTIFICATION; HALLUCINOGEN; ANTAGONISTS; DITERPENES;
D O I
10.1016/j.bmc.2012.02.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3100 / 3110
页数:11
相关论文
共 50 条
  • [41] Antipruritic effects of nalfurafine, the kappa opioid receptor agonist
    Inan, Saadet
    Cowan, Alan
    ACTA DERMATO-VENEREOLOGICA, 2007, 87 (05) : 474 - 474
  • [42] Characterising Kappa Opioid Receptor Expression in Multiple Sclerosis
    Carter, Kirsten
    Pengelly, Bria
    Prisinzano, Thomas
    La Flamme, Anne
    Kivell, Bronwyn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 861 - 861
  • [43] Molecular mechanism of biased signaling at the kappa opioid receptor
    Amal El Daibani
    Joseph M. Paggi
    Kuglae Kim
    Yianni D. Laloudakis
    Petr Popov
    Sarah M. Bernhard
    Brian E. Krumm
    Reid H. J. Olsen
    Jeffrey Diberto
    F. Ivy Carroll
    Vsevolod Katritch
    Bernhard Wünsch
    Ron O. Dror
    Tao Che
    Nature Communications, 14
  • [44] Kappa Opioid Receptor Distribution and Function in Primary Afferents
    Snyder, Lindsey M.
    Chiang, Michael C.
    Loeza-Alcocer, Emanuel
    Omori, Yu
    Hachisuka, Junichi
    Sheahan, Tayler D.
    Gale, Jenna R.
    Adelman, Peter C.
    Sypek, Elizabeth I.
    Fulton, Stephanie A.
    Friedman, Robert L.
    Wright, Margaret C.
    Duque, Melissa Giraldo
    Lee, Yeon Sun
    Hu, Zeyu
    Huang, Huizhen
    Cai, Xiaoyun
    Meerschaert, Kimberly A.
    Nagarajan, Vidhya
    Hirai, Toshiro
    Scherrer, Gregory
    Kaplan, Daniel H.
    Porreca, Frank
    Davis, Brian M.
    Gold, Michael S.
    Koerber, H. Richard
    Ross, Sarah E.
    NEURON, 2018, 99 (06) : 1274 - +
  • [45] Participation of central kappa-opioid receptor in arrhythmogenesis
    Lishmanov, YB
    Maslov, LN
    Ugdyzhekova, DS
    Smagin, GN
    LIFE SCIENCES, 1997, 61 (03) : PL33 - PL38
  • [46] THE KAPPA-OPIOID RECEPTOR - EVIDENCE FOR THE DIFFERENT SUBTYPES
    WOLLEMANN, M
    BENYHE, S
    SIMON, J
    LIFE SCIENCES, 1993, 52 (07) : 599 - 611
  • [47] CUTANEOUS EXPRESSION OF THE KAPPA OPIOID RECEPTOR IN PRURITIC DERMATOSES
    Lotts, Tobias
    Bobko, Svetlana
    Born, Isabel
    Staender, Sonja
    ACTA DERMATO-VENEREOLOGICA, 2013, 93 (05) : 635 - 635
  • [48] SEX DIFFERENCES IN KAPPA OPIOID RECEPTOR SIGNALING IN MICE
    Windisch, K. A.
    Collins, D.
    Reed, B.
    Kreek, M. J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 209A - 209A
  • [49] Kappa opioid receptor is expressed in the rat cerebellar cortex
    Herráez-Baranda, LA
    Carretero, J
    González-Sarmiento, R
    Rodríguez, RE
    CELL AND TISSUE RESEARCH, 2005, 320 (02) : 223 - 228
  • [50] The kappa opioid receptor is associated with the perception of visceral pain
    Black, D
    Trevethick, M
    GUT, 1998, 43 (03) : 312 - 313